Ignite Creation Date:
2024-05-06 @ 7:48 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06140420
Status:
RECRUITING
Last Update Posted:
2023-11-21
First Post:
2023-11-14
Brief Title:
Naltrexone for Prolonged Grief Disorder
Sponsor:
Texas Tech University
Organization:
Texas Tech University
Study Overview
Official Title:
Naltrexone Treatment for Prolonged Grief Disorder A Proof of Concept Study
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NPGD
Brief Summary:
This is a study to see how effective oral naltrexone is as treatment for prolonged grief disorder PGD Participants will take their assigned medication for 8 weeks with monthly visits to assess symptom severity social connectedness and adverse reactions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None